table of content
1 Introduction to Research & Analysis Reports
1.1 Kidney Disease Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Kidney Disease Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Kidney Disease Drugs Overall Market Size
2.1 Global Kidney Disease Drugs Market Size: 2022 VS 2030
2.2 Global Kidney Disease Drugs Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Kidney Disease Drugs Sales: 2018-2030
3 Company Landscape
3.1 Top Kidney Disease Drugs Players in Global Market
3.2 Top Global Kidney Disease Drugs Companies Ranked by Revenue
3.3 Global Kidney Disease Drugs Revenue by Companies
3.4 Global Kidney Disease Drugs Sales by Companies
3.5 Global Kidney Disease Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Kidney Disease Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Kidney Disease Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Kidney Disease Drugs Players in Global Market
3.8.1 List of Global Tier 1 Kidney Disease Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Kidney Disease Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Kidney Disease Drugs Market Size Markets, 2022 & 2030
4.1.2 Tablets
4.1.3 Capsule
4.1.4 Other
4.2 By Type - Global Kidney Disease Drugs Revenue & Forecasts
4.2.1 By Type - Global Kidney Disease Drugs Revenue, 2018-2023
4.2.2 By Type - Global Kidney Disease Drugs Revenue, 2024-2030
4.2.3 By Type - Global Kidney Disease Drugs Revenue Market Share, 2018-2030
4.3 By Type - Global Kidney Disease Drugs Sales & Forecasts
4.3.1 By Type - Global Kidney Disease Drugs Sales, 2018-2023
4.3.2 By Type - Global Kidney Disease Drugs Sales, 2024-2030
4.3.3 By Type - Global Kidney Disease Drugs Sales Market Share, 2018-2030
4.4 By Type - Global Kidney Disease Drugs Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Kidney Disease Drugs Market Size, 2022 & 2030
5.1.2 Chronic Glomerulonephritis
5.1.3 Nephrotic Syndrome
5.1.4 Chronic Renal Failure
5.1.5 Kidney Stones
5.1.6 Renal Cyst (polycystic Kidney)
5.1.7 Diabetic Nephropathy
5.1.8 Hypertensive Nephropathy
5.1.9 Purpura Nephritis
5.1.10 Lupus Nephritis
5.1.11 Pediatric Kidney Disease
5.2 By Application - Global Kidney Disease Drugs Revenue & Forecasts
5.2.1 By Application - Global Kidney Disease Drugs Revenue, 2018-2023
5.2.2 By Application - Global Kidney Disease Drugs Revenue, 2024-2030
5.2.3 By Application - Global Kidney Disease Drugs Revenue Market Share, 2018-2030
5.3 By Application - Global Kidney Disease Drugs Sales & Forecasts
5.3.1 By Application - Global Kidney Disease Drugs Sales, 2018-2023
5.3.2 By Application - Global Kidney Disease Drugs Sales, 2024-2030
5.3.3 By Application - Global Kidney Disease Drugs Sales Market Share, 2018-2030
5.4 By Application - Global Kidney Disease Drugs Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Kidney Disease Drugs Market Size, 2022 & 2030
6.2 By Region - Global Kidney Disease Drugs Revenue & Forecasts
6.2.1 By Region - Global Kidney Disease Drugs Revenue, 2018-2023
6.2.2 By Region - Global Kidney Disease Drugs Revenue, 2024-2030
6.2.3 By Region - Global Kidney Disease Drugs Revenue Market Share, 2018-2030
6.3 By Region - Global Kidney Disease Drugs Sales & Forecasts
6.3.1 By Region - Global Kidney Disease Drugs Sales, 2018-2023
6.3.2 By Region - Global Kidney Disease Drugs Sales, 2024-2030
6.3.3 By Region - Global Kidney Disease Drugs Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Kidney Disease Drugs Revenue, 2018-2030
6.4.2 By Country - North America Kidney Disease Drugs Sales, 2018-2030
6.4.3 US Kidney Disease Drugs Market Size, 2018-2030
6.4.4 Canada Kidney Disease Drugs Market Size, 2018-2030
6.4.5 Mexico Kidney Disease Drugs Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Kidney Disease Drugs Revenue, 2018-2030
6.5.2 By Country - Europe Kidney Disease Drugs Sales, 2018-2030
6.5.3 Germany Kidney Disease Drugs Market Size, 2018-2030
6.5.4 France Kidney Disease Drugs Market Size, 2018-2030
6.5.5 U.K. Kidney Disease Drugs Market Size, 2018-2030
6.5.6 Italy Kidney Disease Drugs Market Size, 2018-2030
6.5.7 Russia Kidney Disease Drugs Market Size, 2018-2030
6.5.8 Nordic Countries Kidney Disease Drugs Market Size, 2018-2030
6.5.9 Benelux Kidney Disease Drugs Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Kidney Disease Drugs Revenue, 2018-2030
6.6.2 By Region - Asia Kidney Disease Drugs Sales, 2018-2030
6.6.3 China Kidney Disease Drugs Market Size, 2018-2030
6.6.4 Japan Kidney Disease Drugs Market Size, 2018-2030
6.6.5 South Korea Kidney Disease Drugs Market Size, 2018-2030
6.6.6 Southeast Asia Kidney Disease Drugs Market Size, 2018-2030
6.6.7 India Kidney Disease Drugs Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Kidney Disease Drugs Revenue, 2018-2030
6.7.2 By Country - South America Kidney Disease Drugs Sales, 2018-2030
6.7.3 Brazil Kidney Disease Drugs Market Size, 2018-2030
6.7.4 Argentina Kidney Disease Drugs Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Kidney Disease Drugs Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Kidney Disease Drugs Sales, 2018-2030
6.8.3 Turkey Kidney Disease Drugs Market Size, 2018-2030
6.8.4 Israel Kidney Disease Drugs Market Size, 2018-2030
6.8.5 Saudi Arabia Kidney Disease Drugs Market Size, 2018-2030
6.8.6 UAE Kidney Disease Drugs Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Kidney Disease Drugs Major Product Offerings
7.1.4 GlaxoSmithKline Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Sanofi
7.2.1 Sanofi Company Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Kidney Disease Drugs Major Product Offerings
7.2.4 Sanofi Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Sanofi Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche Kidney Disease Drugs Major Product Offerings
7.3.4 Roche Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Roche Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Kidney Disease Drugs Major Product Offerings
7.4.4 Pfizer Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Pfizer Key News & Latest Developments
7.5 AstraZeneca
7.5.1 AstraZeneca Company Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Kidney Disease Drugs Major Product Offerings
7.5.4 AstraZeneca Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.5.5 AstraZeneca Key News & Latest Developments
7.6 Keryx Biopharmaceuticals
7.6.1 Keryx Biopharmaceuticals Company Summary
7.6.2 Keryx Biopharmaceuticals Business Overview
7.6.3 Keryx Biopharmaceuticals Kidney Disease Drugs Major Product Offerings
7.6.4 Keryx Biopharmaceuticals Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Keryx Biopharmaceuticals Key News & Latest Developments
7.7 Kissei Pharmaceutical
7.7.1 Kissei Pharmaceutical Company Summary
7.7.2 Kissei Pharmaceutical Business Overview
7.7.3 Kissei Pharmaceutical Kidney Disease Drugs Major Product Offerings
7.7.4 Kissei Pharmaceutical Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Kissei Pharmaceutical Key News & Latest Developments
7.8 AbbVie
7.8.1 AbbVie Company Summary
7.8.2 AbbVie Business Overview
7.8.3 AbbVie Kidney Disease Drugs Major Product Offerings
7.8.4 AbbVie Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.8.5 AbbVie Key News & Latest Developments
7.9 Amgen
7.9.1 Amgen Company Summary
7.9.2 Amgen Business Overview
7.9.3 Amgen Kidney Disease Drugs Major Product Offerings
7.9.4 Amgen Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Amgen Key News & Latest Developments
7.10 Teva Pharmaceutical Industries
7.10.1 Teva Pharmaceutical Industries Company Summary
7.10.2 Teva Pharmaceutical Industries Business Overview
7.10.3 Teva Pharmaceutical Industries Kidney Disease Drugs Major Product Offerings
7.10.4 Teva Pharmaceutical Industries Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.11 Tianjin Tongrentang Group
7.11.1 Tianjin Tongrentang Group Company Summary
7.11.2 Tianjin Tongrentang Group Kidney Disease Drugs Business Overview
7.11.3 Tianjin Tongrentang Group Kidney Disease Drugs Major Product Offerings
7.11.4 Tianjin Tongrentang Group Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Tianjin Tongrentang Group Key News & Latest Developments
7.12 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical
7.12.1 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Company Summary
7.12.2 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Business Overview
7.12.3 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Major Product Offerings
7.12.4 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Key News & Latest Developments
7.13 Datong Liqun Pharmaceutical
7.13.1 Datong Liqun Pharmaceutical Company Summary
7.13.2 Datong Liqun Pharmaceutical Kidney Disease Drugs Business Overview
7.13.3 Datong Liqun Pharmaceutical Kidney Disease Drugs Major Product Offerings
7.13.4 Datong Liqun Pharmaceutical Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Datong Liqun Pharmaceutical Key News & Latest Developments
7.14 Hebei Ruisen Pharmaceutical
7.14.1 Hebei Ruisen Pharmaceutical Company Summary
7.14.2 Hebei Ruisen Pharmaceutical Business Overview
7.14.3 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Major Product Offerings
7.14.4 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Hebei Ruisen Pharmaceutical Key News & Latest Developments
7.15 Changxing Pharmaceutical
7.15.1 Changxing Pharmaceutical Company Summary
7.15.2 Changxing Pharmaceutical Business Overview
7.15.3 Changxing Pharmaceutical Kidney Disease Drugs Major Product Offerings
7.15.4 Changxing Pharmaceutical Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.15.5 Changxing Pharmaceutical Key News & Latest Developments
7.16 zhejiang Shengbokang Pharmaceutical
7.16.1 zhejiang Shengbokang Pharmaceutical Company Summary
7.16.2 zhejiang Shengbokang Pharmaceutical Business Overview
7.16.3 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Major Product Offerings
7.16.4 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.16.5 zhejiang Shengbokang Pharmaceutical Key News & Latest Developments
8 Global Kidney Disease Drugs Production Capacity, Analysis
8.1 Global Kidney Disease Drugs Production Capacity, 2018-2030
8.2 Kidney Disease Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Kidney Disease Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Kidney Disease Drugs Supply Chain Analysis
10.1 Kidney Disease Drugs Industry Value Chain
10.2 Kidney Disease Drugs Upstream Market
10.3 Kidney Disease Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Kidney Disease Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
